Two Top Stocks to Keep an Eye on: Northern Oil and Gas, Inc. (NYSE:NOG), Cardiome Pharma Corp. (NASDAQ:CRME)

Northern Oil and Gas, Inc. (NYSE:NOG)

The shares of Northern Oil and Gas, Inc. (NYSE:NOG) started off the last trading session with the price of $2 while closing the day with the price of $1.75. The shares of Northern Oil and Gas, Inc. (NYSE:NOG) Fell -23.91% with the Loss of -0.25 points.

The shares of Northern Oil and Gas, Inc. (NYSE:NOG) traded with the day volume of 5.1 Million shares whereas its average trading volume is 1.79 Million.

While analyzing the past performance of the stock we can see that the shares of Northern Oil and Gas, Inc. (NYSE:NOG) Loss -17.06% in the last week while Falling -7.89% in the last month. Past quarter performance shows the green light with 13.64%. The semi-annual and annual performance shows 108.33% and -36.36% respectively.

Some critical values of the shares of Northern Oil and Gas, Inc. (NYSE:NOG) to be discussed here are: the beta which shows the value at 1.58 while Average True Range of Northern Oil and Gas, Inc. (NYSE:NOG) demonstrate the value at 0.19. The weekly and monthly volatility of the shares of Northern Oil and Gas, Inc. (NYSE:NOG) are indicated at 7.89% and 8.14%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 38.03.

While studying the financial position of the shares of Northern Oil and Gas, Inc. (NYSE:NOG), we can see that the Market capitalization of the company is at 113.72 Million. The shares outstanding for the company is 64.98 Million and the shares float stands at 41.62 Million. The income of the company stand at -10000000 while the sales stand at 209.3 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.15, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 0.54, the Return on Asset ROA stood at -0.018 and the Return on Equity ROE depicted at 0.019 while Return on Investment ROI is at 0.123.


Cardiome Pharma Corp. (NASDAQ:CRME)

Cardiome Pharma Corp. (NASDAQ:CRME) started its previous trading session at $2.2 and closed at $1.79 showing a Rise of 14.01 Percent.

The Company traded with an average Volume of 67.28 Million whereas, its Day Volume stood at 5.08 Million.

Looking at the performance of the stock, Cardiome Pharma Corp. (NASDAQ:CRME) Gain 7.83% in the last week in its shares price and 21.77% in the last month. Quarterly performance shows a green of 20.13 Percent while Semi-Annual and Annual performances shows a -22.51 and -42.24 percent respectively.

Beta for Cardiome Pharma Corp. (NASDAQ:CRME) stands at 0.72 while the ATR (average true range) is at 0.15. The Stock’s Weekly and Monthly Volatility is 12.19% and 7.58% respectively showing a RSI value of 64.2.

While studying the financial position of the shares of Cardiome Pharma Corp. (NASDAQ:CRME), we can see that the Market capitalization of the company is at 60.57 Million. The shares outstanding for the company is 33.84 Million and the shares float stands at 33.78 Million.

The Company generated an income of -27100000 and the sales of 24 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.83 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 2.52 respectively.

The Return on Assets stands at -0.402, ROE shows a value of -0.946 and ROI for Cardiome Pharma Corp. (NASDAQ:CRME) is -0.302 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment